Antiseptic And Disinfectant Market Size, Share, Opportunities, And Trends By Type (Quaternary Ammonium Compounds, Chlorine Compounds, Alcohols & Aldehyde Products, Enzyme, Others), By Product (Enzymatic Cleaners, Medical Device Disinfectants, Surface Disinfectants), By End-Use (Hospitals, Clinics, Others), And By Geography - Forecasts From 2023 To 2028

  • Published : Dec 2023
  • Report Code : KSI061615753
  • Pages : 148

The antiseptic and disinfectant market is estimated to grow at a CAGR of 12.38% during the forecast period.

Antiseptics are used in healthcare facilities for a wide range of topical and hard-surface applications. In contrast to antibiotics, the majority of these active compounds have broad-spectrum antimicrobial activity, although little is known about their method of action. Since antiseptics and disinfectants are used widely, there has been significant discussion over the emergence of microbial resistance, particularly about whether antimicrobial resistance is brought on by antiseptics or disinfectants.

Growth drivers fueling the antiseptic and disinfectant market

Rising instances of illness caused due to infections are a major growth driver for the antiseptic and disinfectant market. Precautions must be taken by people as the population around the world is prone to illness caused by infections. Extensive R&D programs are being carried out by industry leaders to manufacture new and improved products which is propelling the antiseptic and disinfectant market share. The growing investment by these manufacturers has also emerged as a crucial factor for the antiseptic and disinfectant market growth.

Rising incidence of HAIs

One of the main drivers of antiseptic and disinfectant market expansion is the rising prevalence of HAIs brought on by a lack of sanitation and safety measures. For instance, Healthcare-Associated Infections estimated that at least one HAI is required annually by approximately one in every twenty-five patients present in the hospital. Antiseptics and disinfectants play a significant role in overall contamination, prevention and lowering the frequency of HAIs. Antiseptic and disinfectant products protect the patient's body from any bacterial and microbial infections, which is further propelling the antiseptic and disinfectant market.

Multiple reimbursement policies are a major growth opportunity

Many attractive reimbursement plans are being offered by insurance firms to customers that would help them select cutting-edge technologies for treatment leading to antiseptic and disinfectant market growth. Reimbursement strategies are encouraged to make treatment options accessible for these people despite their low disposable income. As the number of people suffering from infectious illness increases the number of reimbursements that are being authorized also increases.

Surface disinfectants are showing growth potential

Chemical substances known as surface disinfectants are used to kill or render inactive bacteria on inert surfaces. These disinfectants function by rupturing microorganisms' cell walls or obstructing their metabolism. Infections that do not exist or are not incubating at the time a patient is admitted can be avoided by performing thorough surface cleaning. Surface disinfectants utilize several chemicals for various objectives. In non-healthcare contexts, sodium hypochlorite (bleach/chlorine) may be used at a recommended dosage of 0.1% or 1,000 ppm, according to World Health Organisation (WHO) data revised in March 2022. Also useful for surface sanitation is alcohol at 70–90% concentration.

Medical device disinfectants are anticipated to grow significantly

Surgical units and endoscopes are often reprocessed using medical equipment disinfectants. Phenol, hydrogen peroxide, peracetic acid, and glutaraldehyde are some of the disinfectants used for reprocessing or disinfecting medical devices. The risk of infection spreading from patient to patient due to skin contact is the reason why endoscopes and medical devices need to be disinfected. The rising number of surgical operations being performed globally is one of the primary factors propelling the antiseptic and disinfectant market growth.

Increasing demand for alcohol-based disinfectants

Alcohol-based disinfectants are utilized on clinical instruments due to their effectiveness in eliminating a wide variety of bacteria. They are ideal for medical applications because they are also simple to use and non-toxic. Disinfecting endoscopes is one of the main uses for clinical equipment. Endoscopes are often sterilized and cleaned using alcohol-based disinfectants. They efficiently eradicate many germs, including fungi, bacteria, and viruses. Thus, the growing need for alcohol-based disinfectants for medical equipment will probably promote antiseptic and disinfectant market expansion.

North America is anticipated to be the largest glaucoma market shareholder

North America is predicted to be the leading antiseptic and disinfectant market shareholder due to the increasing number of healthcare personnel working in North America and the growing number of operations, the demand for disinfectants and antiseptics in the region is anticipated to increase. Antiseptic and disinfection treatments are crucial for surgical procedures and scientific research because they minimize the danger of infection and contamination transferring from one patient to another. Furthermore, the region is experiencing growth due to a rise in the incidence of hospital-acquired infections and the adaption of doctor-prescribed infection therapies.

Key players focus on product innovation

Based on the level of protection necessary for various occupational hazards, antiseptics and disinfectant manufacturing businesses utilize novel and cutting-edge technologies to create, manufacture, and distribute goods to a variety of end consumers which is crucial in the expansion of antiseptic and disinfectant market share. For instance, Health Canada added five SC Johnson household cleaning products to its list of effective disinfectants for use against SARS-CoV-2 in January 2021. These disinfectants have been authorized by SC Johnson to destroy SARS-CoV-2, the virus that generates COVID-19 symptoms like bubbles when you scrub. The COVID-19 pandemic, therefore, had a favourable commercial impact as a result of previous and ongoing developments made by numerous firms.

Market Key Developments

  • In October 2022, Cororid disinfection products were introduced by Deepak Fertilisers And Petrochemicals Corporation (DFPCL) to meet the unique requirements of hospitals, clinics, labs, and other medical and healthcare setups.
  • In September 2022, Reckitt and its brand Dettol announced a partnership with delivery service and local travel leaders Deliveroo, SF Express, and Uber to safeguard the daily needs of Hong Kong residents by enhancing the hygiene standards of their services with visible disinfectants.
  • In August 2022, PDI announced the dual introduction of unique, innovative disinfectants to aid infection prevention experts in the ongoing fight against COVID-19 and the growing number of healthcare-associated infections (HAIs).

Antiseptic and Disinfectant Market Scope:


Report Metric Details
Growth Rate CAGR of 12.38% from 2021 to 2028
Base Year 2021
Forecast Period 2023 – 2028
Forecast Unit (Value) USD Billion
Segments Covered Type, Product, End-Use, and Geography
Regions Covered North America, South America, Europe, Middle East and Africa, Asia Pacific
Companies Covered PSK Pharma, ACTO GmbH, Dr. Schumacher GmbH, 3M, Reckitt Benckiser, Steris Plc, Kimberly-Clark Corporation, Cardinal Health, BD
Customization Scope Free report customization with purchase



  • By Type
    • Quaternary Ammonium Compounds
    • Chlorine Compounds
    • Alcohols & Aldehyde Products
    • Enzyme
    • Others
  • By Product
    • Enzymatic Cleaners
    • Medical Device Disinfectants
    • Surface Disinfectants
  • By End-Use
    • Hospitals
    • Clinics
    • Others
  • By Geography
    • North America
      • United States
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • United Kingdom
      • Germany
      • France
      • Spain
      • Others
    • Middle East and Africa
      • Saudi Arabia
      • UAE
      • Israel
      • Others
    • Asia Pacific
      • Japan
      • China
      • India
      • South Korea
      • Indonesia
      • Thailand
      • Others


1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base, and Forecast Years Timeline


2.1. Research Data

2.2. Assumptions


3.1. Research Highlights


4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Force Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis


5.1. Introduction

5.2. Quaternary Ammonium Compounds

5.3. Chlorine Compounds

5.4. Alcohols & Aldehyde Products

5.5. Enzyme

5.6. Others


6.1. Introduction

6.2. Enzymatic Cleaners

6.3. Medical Device Disinfectants

6.4. Surface Disinfectants


7.1. Introduction

7.2. Hospitals

7.3. Clinics

7.4. Others


8.1. Introduction

8.2. North America

8.2.1. United States

8.2.2. Canada

8.2.3. Mexico

8.3. South America

8.3.1. Brazil

8.3.2. Argentina

8.3.3. Others

8.4. Europe

8.4.1. United Kingdom

8.4.2. Germany

8.4.3. France

8.4.4. Spain

8.4.5. Others

8.5. The Middle East and Africa

8.5.1. Saudi Arabia

8.5.2. UAE

8.5.3. Israel

8.5.4. Others

8.6. Asia Pacific

8.6.1. Japan

8.6.2. China

8.6.3. India

8.6.4. South Korea

8.6.5. Indonesia

8.6.6. Thailand

8.6.7. Others


9.1. Major Players and Strategy Analysis

9.2. Emerging Players and Market Lucrativeness

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Vendor Competitiveness Matrix


10.1. PSK Pharma

10.2. ACTO GmbH

10.3. Dr. Schumacher GmbH

10.4. 3M

10.5. Reckitt Benckiser

10.6. Steris Plc

10.7. Kimberly-Clark Corporation

10.8. Cardinal Health

10.9. BD

PSK Pharma


Dr. Schumacher GmbH


Reckitt Benckiser

Steris Plc

Kimberly-Clark Corporation

Cardinal Health